In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2 '')-Id gene

Authors
Kak, V You, I Zervos, MJ Kariyama, R Kumon, H Chow, JW
Citation
V. Kak et al., In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2 '')-Id gene, DIAG MICR I, 37(4), 2000, pp. 297-299
Citations number
16
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Microbiology
Journal title
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
ISSN journal
07328893 → ACNP
Volume
37
Issue
4
Year of publication
2000
Pages
297 - 299
Database
ISI
SICI code
0732-8893(200008)37:4<297:ISAOTC>2.0.ZU;2-C
Abstract
The combination of ampicillin plus arbekacin produced synergistic killing a gainst 8 of 13 vancomycin-, ampicillin-, gentamicin-, and streptomycin-resi stant Enterococcus faecium isolates that possess the high-level gentamicin resistance gene, nph(2 ")-Id. This combination may prove useful in treating infections caused by multiresistant enterococci. (C) 2000 Elsevier Science Inc. All rights reserved.